SAB Biotherapeutics, Inc.
SABS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001833214
No open-market purchases or sales by SAB Biotherapeutics, Inc. insiders were filed in the last 90 days; 87 institutions reported holding it in 13F filings for Q2 2026, worth $266.8M in total; no superinvestor holds it.
Other share classesSABSW
13F holders, Q4 2022
Institutional positions in SAB Biotherapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 38
- 0 vs. Q3 2022
- Shares held
- 4.09M
- +807.8K (+24.6%) vs. Q3 2022
- Total value
- $2.42M
- +$113.1K (+4.9%) vs. Q3 2022
- New holders
- 8
- 9 more added
- Sold out
- 8
- 9 more reduced
2 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SABS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 87 | $266.8M |
| Q1 2026 | 76 | $265.0M |
| Q4 2025 | 48 | $135.9M |
| Q3 2025 | 34 | $56.3M |
| Q2 2025 | 25 | $3.37M |
| Q1 2025 | 26 | $2.99M |
| Q4 2024 | 25 | $10.1M |
| Q3 2024 | 25 | $8.48M |
| Q2 2024 | 22 | $9.69M |
| Q1 2024 | 24 | $15.2M |
| Q4 2023 | 42 | $24.5M |
| Q3 2023 | 34 | $2.41M |
| Q2 2023 | 38 | $3.28M |
| Q1 2023 | 39 | $1.71M |
| Q4 2022 | 38 | $2.42M |
| Q3 2022 | 40 | $2.32M |
| Q2 2022 | 37 | $4.45M |
| Q1 2022 | 27 | $6.71M |
| Q4 2021 | 34 | $25.4M |
| Q3 2021 | 1 | $605.0K |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding SAB Biotherapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| First PREMIER Bank | 807,535 | $476.0K | 0.14% | 00.0% | Unchanged |
| Vanguard Group Inc | 701,584 | $413.9K | 0.00% | +581+0.1% | Added |
| Veritable, L.P. | 506,513 | $298.8K | 0.01% | +462,962+1,063.0% | Added |
| Warberg Asset Management LLC | 370,370 | $218.5K | 0.07% | +370,370 | New |
| Geode Capital Management, LLC | 300,529 | $177.0K | 0.00% | −16,134−5.1% | Reduced |
| Shaolin Capital Management LLC | 236,621 | $140.0K | 0.00% | −38,379−14.0% | Reduced |
| Institutional & Family Asset Management, LLC | 149,774 | $88.4K | 0.01% | 00.0% | Unchanged |
| Meteora Capital, LLC | 134,524 | $79.4K | 0.02% | −115,001−46.1% | Reduced |
| Citadel Advisors LLC | 109,215 | $64.4K | 0.00% | +69,053+171.9% | Added |
| BlackRock Inc. | 108,153 | $63.8K | 0.00% | −17,569−14.0% | Reduced |
| Bridgeway Capital Management, LLC | 84,000 | $49.6K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 81,241 | $47.9K | 0.00% | 00.0% | Unchanged |
| HighTower Advisors, LLC | 75,970 | $44.0K | 0.00% | +75,970 | New |
| Mariner, LLC | 69,000 | $41.0K | 0.00% | 00.0% | Unchanged |
| Silver Oak Securities, Inc | 51,941 | $31.0K | 0.01% | +51,941 | New |
| Creative Planning | 48,518 | $28.6K | 0.00% | +1,000+2.1% | Added |
| Northern Trust Corp | 44,476 | $26.2K | 0.00% | 00.0% | Unchanged |
| LGL Partners, LLC | 23,000 | $13.6K | 0.00% | 00.0% | Unchanged |
| Brookstone Capital Management | 21,755 | $13.3K | 0.00% | +5,290+32.1% | Added |
| Advisor Group Holdings, Inc. | 19,096 | $11.3K | 0.00% | +16,883+762.9% | Added |
| AE Wealth Management LLC | 18,700 | $11.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 17,207 | $10.2K | 0.00% | −7,864−31.4% | Reduced |
| Charles Schwab Investment Management Inc | 16,238 | $9.58K | 0.00% | 00.0% | Unchanged |
| Elgethun Capital Management | 14,796 | $9.17K | 0.00% | +1,500+11.3% | Added |
| Nadler Financial Group, Inc. | 13,750 | $8.11K | 0.00% | +13,750 | New |
| Tower Research Capital LLC (TRC) | 11,411 | $7.00K | 0.00% | −2,231−16.4% | Reduced |
| Susquehanna International Group, LLP | 11,441 | $6.75K | 0.00% | +11,441 | New |
| Kestra Advisory Services, LLC | 11,000 | $6.49K | 0.00% | 00.0% | Unchanged |
| Baird Financial Group, Inc. | 10,000 | $6.00K | 0.00% | +10,000 | New |
| 1st Source Bank | 10,000 | $5.90K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 6,927 | $4.09K | 0.00% | +5,423+360.6% | Added |
| Royal Bank of Canada | 4,820 | $3.00K | 0.00% | −299−5.8% | Reduced |
| JPMorgan Chase & Co | 881 | $1.00K | 0.00% | −1,744−66.4% | Reduced |
| Money Concepts Capital Corp | 250 | $147 | 0.00% | +250 | New |
| Wells Fargo & Company | 185 | $109 | 0.00% | +5+2.8% | Added |
| Bank of America Corp | 38 | $22 | 0.00% | −432−91.9% | Reduced |
| Rockefeller Capital Management L.P. | 1,500 | $0 | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 145 | $0 | 0.00% | +145 | New |
| Millennium Management LLC | 0 | $0 | 0.00% | −38,547−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −23,954−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −12,618−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −9,000−100.0% | Sold out |
| Wolverine Asset Management LLC | 0 | $0 | 0.00% | −3,926−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −494−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −127−100.0% | Sold out |
| China Universal Asset Management Co., Ltd. | 0 | $0 | 0.00% | −403−100.0% | Sold out |
| American Portfolios Advisors | – | – | – | – | Not filed |
| Spectrum Management Group, LLC | – | – | – | – | Not filed |